Published in Am J Med on May 01, 1998
Trends in smokeless tobacco use among adults and adolescents in the United States. Am J Public Health (2006) 2.43
A fresh look at tobacco harm reduction: the case for the electronic cigarette. Harm Reduct J (2013) 1.93
A pilot study of smokeless tobacco in smoking cessation. Am J Med (1998) 3.60
A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med (1999) 10.62
Quantitative evaluation of Escherichia coli host strains for tolerance to cytosine methylation in plasmid and phage recombinants. Nucleic Acids Res (1989) 7.78
The effectiveness of the nicotine patch for smoking cessation. A meta-analysis. JAMA (1994) 6.02
Trends in cigarette smoking in the United States. Educational differences are increasing. JAMA (1989) 5.59
Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research. JAMA (1997) 5.47
Trends in cigarette smoking in the United States. Projections to the year 2000. JAMA (1989) 4.90
Predicting smoking cessation. Who will quit with and without the nicotine patch. JAMA (1994) 3.83
Tobacco dependence and the nicotine patch. Clinical guidelines for effective use. JAMA (1992) 3.77
The reliability of self-reported cigarette consumption in the United States. Am J Public Health (1989) 3.35
Development and validation of the Wisconsin Smoking Withdrawal Scale. Exp Clin Psychopharmacol (1999) 3.21
Gender differences in smoking cessation. J Consult Clin Psychol (1999) 2.84
Varying nicotine patch dose and type of smoking cessation counseling. JAMA (1995) 2.82
Evaluation of a blood-free, charcoal-based, selective medium for the isolation of Campylobacter organisms from feces. J Clin Microbiol (1986) 2.79
The motivation to use drugs: a psychobiological analysis of urges. Nebr Symp Motiv (1986) 2.56
Cigarette smoking prevalence by occupation in the United States. A comparison between 1978 to 1980 and 1987 to 1990. J Occup Med (1994) 2.52
US public health service clinical practice guideline: treating tobacco use and dependence. Respir Care (2000) 2.44
Quitting smoking in the United States in 1986. J Natl Cancer Inst (1990) 2.42
Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic. Clin Pharmacol Ther (2011) 2.33
Smoking status as the new vital sign: effect on assessment and intervention in patients who smoke. Mayo Clin Proc (1995) 2.32
Postcessation cigarette use: the process of relapse. Addict Behav (1990) 2.21
Smoking withdrawal dynamics in unaided quitters. J Abnorm Psychol (2000) 2.11
Hairpins are formed by the single DNA strands of the fragile X triplet repeats: structure and biological implications. Proc Natl Acad Sci U S A (1995) 2.10
Smoking outcome expectancies: factor structure, predictive validity, and discriminant validity. J Abnorm Psychol (1994) 2.06
Profiles in discouragement: two studies of variability in the time course of smoking withdrawal symptoms. J Abnorm Psychol (1998) 1.84
RglB facilitated cloning of highly methylated eukaryotic DNA: the human L1 transposon, plant DNA, and DNA methylated in vitro with human DNA methyltransferase. Nucleic Acids Res (1988) 1.71
Race/ethnicity and the 2000 census: implications for public health. Am J Public Health (2000) 1.61
Smoking cessation treatment and the good doctor club. Am J Public Health (1995) 1.60
CFTR activation: additive effects of stimulatory and inhibitory phosphorylation sites in the R domain. Am J Physiol (1997) 1.57
CFTR: mechanism of anion conduction. Physiol Rev (1999) 1.55
Response to nicotine dependence treatment in smokers with current and past alcohol problems. Ann Behav Med (1999) 1.54
Gender differences in response to nicotine replacement therapy: objective and subjective indexes of tobacco withdrawal. Exp Clin Psychopharmacol (1999) 1.47
The effects of athletic massage on delayed onset muscle soreness, creatine kinase, and neutrophil count: a preliminary report. J Orthop Sports Phys Ther (1994) 1.40
Short-term exposure to a neuroactive steroid increases alpha4 GABA(A) receptor subunit levels in association with increased anxiety in the female rat. Brain Res (2001) 1.36
Trends in smoking by age and sex, United States, 1974-1987: the implications for disease impact. Prev Med (1990) 1.35
DNA adduct 8-hydroxyl-2'-deoxyguanosine (8-hydroxyguanine) affects function of human DNA methyltransferase. Carcinogenesis (1995) 1.31
Transdermal nicotine replacement for hospitalized patients: a randomized clinical trial. Prev Med (1998) 1.31
Cystic fibrosis transmembrane conductance regulator (CFTR) anion binding as a probe of the pore. Biophys J (1998) 1.30
Relation between self-reported affect and drug urges and cravings in continuing and withdrawing smokers. J Abnorm Psychol (1992) 1.29
Evaluating the construct validity of psychopathy in black and white male inmates: three preliminary studies. J Abnorm Psychol (1990) 1.24
Are higher doses of nicotine replacement more effective for smoking cessation? Nicotine Tob Res (1999) 1.22
Using brain MERMER testing to detect knowledge despite efforts to conceal. J Forensic Sci (2001) 1.22
Gender and racial/ethnic differences in tobacco-dependence treatment: a commentary and research recommendations. Nicotine Tob Res (2001) 1.20
Measures of affect and nicotine dependence predict differential response to smoking cessation treatments. J Consult Clin Psychol (1992) 1.19
Any further progress in smoking cessation treatment? Nicotine Tob Res (2001) 1.18
Manipulating smoking motivation: impact on an electrophysiological index of approach motivation. J Abnorm Psychol (1999) 1.17
Assessing the generalizability of smoking studies. Addiction (1997) 1.17
Approach and avoidance motivation in psychopathic criminal offenders during passive avoidance. J Pers Soc Psychol (1997) 1.17
Purification of human DNA (cytosine-5-)-methyltransferase. J Cell Biochem (1985) 1.16
Cost-benefit analysis of sustained-release bupropion, nicotine patch, or both for smoking cessation. Prev Med (2000) 1.14
Two studies of the clinical effectiveness of the nicotine patch with different counseling treatments. Chest (1994) 1.13
Size of the directing moiety at carbon 5 of cytosine and the activity of human DNA(cytosine-5) methyltransferase. Biochem Biophys Res Commun (1987) 1.12
Quantification of lumbar function. Part 2: Sagittal plane trunk strength in chronic low-back pain patients. Spine (Phila Pa 1976) (1985) 1.10
Anxiogenic effects of neurosteroid exposure: sex differences and altered GABAA receptor pharmacology in adult rats. J Pharmacol Exp Ther (2003) 1.09
Smokeless tobacco use in the United States: the adult use of tobacco surveys. NCI Monogr (1989) 1.09
Carcinoma of the breast. A clinical study. Arch Surg (1978) 1.05
Characterization of tobacco withdrawal symptoms: transdermal nicotine reduces hunger and weight gain. Psychopharmacology (Berl) (1996) 1.04
The epidemiology of tobacco use, dependence, and cessation in the United States. Prim Care (1999) 1.04
Progesterone withdrawal I: pro-convulsant effects. Brain Res (1998) 1.03
Initial ATP Formation, NADP Reduction, CO(2) Fixation, and Chloroplast Flattening Upon Illuminating Pea Leaves. Plant Physiol (1969) 1.01
The influence of agarose--DNA affinity on the electrophoretic separation of DNA fragments in agarose gels. Anal Biochem (1983) 0.98
Sex differences in anxiety, sensorimotor gating and expression of the alpha4 subunit of the GABAA receptor in the amygdala after progesterone withdrawal. Eur J Neurosci (2003) 0.98
Tobacco withdrawal and nicotine replacement influence objective measures of sleep. J Consult Clin Psychol (1995) 0.98
Reversal of somatostatin inhibition of insulin and glucagon secretion. Diabetes (1976) 0.97
Under-use of tobacco dependence treatment among Wisconsin's fee-for-service Medicaid recipients. WMJ (2001) 0.96
Progesterone withdrawal. II: insensitivity to the sedative effects of a benzodiazepine. Brain Res (1998) 0.96